HIGHER-RISK MYELODYSPLASTIC SYNDROME
Clinical trials for HIGHER-RISK MYELODYSPLASTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new HIGHER-RISK MYELODYSPLASTIC SYNDROME trials appear
Sign up with your email to follow new studies for HIGHER-RISK MYELODYSPLASTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat blood cancers?
Disease control Recruiting nowThis early-stage trial is testing a new drug called CCS1477 in people with advanced blood cancers such as leukemia, lymphoma, and multiple myeloma. The study aims to see if the drug is safe and can shrink tumors. About 250 participants will receive the drug alone or with other tr…
Matched conditions: HIGHER-RISK MYELODYSPLASTIC SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: CellCentric Ltd. • Aim: Disease control
Last updated May 01, 2026 20:57 UTC
-
New hope for tough blood cancers: first human trial of GEN3018 begins
Disease control Recruiting nowThis early-stage trial tests a new antibody drug, GEN3018, in people whose acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) has returned or stopped responding to treatment. The main goal is to check safety and find the best dose. Up to 78 participants will…
Matched conditions: HIGHER-RISK MYELODYSPLASTIC SYNDROME
Phase: PHASE1 • Sponsor: Genmab • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC